Introduction
The many physiological and pathological conditions in which serum prolactin levels are consistently raised are usually associated in women with amenorrhoea. Prolactin is increased when hypothalamic control of the pituitary is lost, presumably because of a lowered secretion of prolactin-inhibiting factor." Recently it has been shown in vitro that raised prolactin levels may inhibit ovarian steroid biosynthesis.2 It has therefore been suggested that in-vivo steroid feedback to the hypothalamicpituitary unit is reduced, with subsequent amenorrhoea.3 Prolactin could also conceivably inhibit directly 
Methods
Patients.-Fourteen patients with consistently raised serum prolactin levels and amenorrhoea of more than 12 months' duration were investigated. Five presented with accompanying galactorrhoea, galactorrhoea was first noted on examination of the breasts in eight, and in the remaining patient only clear serous fluid could be expressed from the breasts. Patients with radiologically apparent pituitary tumours were excluded from this study.
Test Procedure.-Oestradiol benzoate B.P. 1 mg was given intramuscularly and venous blood samples taken at 0 hours and after 24, 48, 56, 72, and 96 hours. Serum oestradiol and progesterone were estimated at 0 hours to exclude recent ovulation and LH and FSH were measured in all samples. A positive response was defined as an increase in LH of 8 U/I and in FSH of 3 U/I above mean baseline values within 96 hours.8 The gonadotrophin release in response to LH-RH was assessed in all patients after injection of 100 isg LH-RH (Hoechst Pharmaceuticals) as previously described. 9 Hormone Measurements.-Serum LH, FSH, oestradiol, and progesterone were estimated using specific radioimmunoassays (R.I.A.).9 Serum prolactin was measured by a double antibody R.I.A. using a modification of Sinha et al.'s method. 10 The prolactin preparation HPr V-L-S No. 1, supplied by the National Institute of Arthritis and Metabolic Diseases, U.S.A., was used as standard and label. Iodination was by the method of Redshaw and Lynch" using sodium hypochlorite 1 mmol/l as an oxidant. The product was passed through Sephadex (Pharmacia Fine Chemicals, Sweden) G25 and G100 columns before use to remove free iodide and polymerized fig.) . The remaining 13 failed to release gonadotrophin (see fig., case 11). In conclusion, our results suggest that there is a hypothalamic abnormality of oestrogen feedback mechanisms as well as the possible hypothalamic defect causing hyperprolactinaemia. Suppression of raised serum prolactin levels is associated with a return of normal hypothalamic-pituitary and ovarian function, but the precise mechanism is unknown. Our data suggest that the return of normal function could be due partly to a restoration of normal oestrogen feedback.
